International Stem Cell (ISCO) Receivables - Net (2010 - 2026)

International Stem Cell (ISCO) has reported Receivables - Net for 17 consecutive years, with $959000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Receivables - Net fell 12.9% year-over-year to $959000.0 in Q2 2026; TTM through Jun 2026 was $959000.0, a 12.9% decrease from a year earlier, with the FY2025 full-year figure at $723000.0, down 31.66% from the prior year.
• Receivables - Net was $959000.0 for Q2 2026 at International Stem Cell, up from $723000.0 in the prior quarter.
• Over five years, Receivables - Net peaked at $1.1 million in Q2 2025 and troughed at $427000.0 in Q3 2022.
• A 5-year average of $772705.9 and a median of $723000.0 in 2025 frame the typical range for Receivables - Net.
• The widest YoY moves for Receivables - Net: up 106.41% in 2022, down 36.08% in 2022.
• Over 5 years, Receivables - Net stood at $747000.0 in 2022, then slipped by 23.16% to $574000.0 in 2023, then surged by 84.32% to $1.1 million in 2024, then sank by 31.66% to $723000.0 in 2025, then soared by 32.64% to $959000.0 in 2026.
• The last three Receivables - Net figures came in at $959000.0 (Q2 2026), $723000.0 (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.